Abstract Library

#1399 High Grade Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET). Instituto Oncologico Nacional. Panama City, Panama. 2004-2015

Introduction: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are relatively rare and complex neoplasms that present many clinical challenges. High grade at diagnosis is an adverse prognostic factor

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Moreno-Ríos J

Authors: Moreno-Ríos J, Vergara R, Lim M, Castillo-Fernandez O,

Keywords: neuroendocrine tumors, neoplasm, unknown primary, High grade,

#1384 Gastroenteropancreatic Neuroendocrine Tumors. Ten Year Experience at Instituto Oncologico Nacional. Panama 2004-2015.

Introduction: Gastroenteropancreatic neuroendocrine tumours (GEP-NET) are rare neoplasm with a rising incidence worldwide.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Castillo-Fernandez O, Vergara R, Moreno-Ríos J, Cukier M, Tapia H,

Keywords: grade, prognosis, neuroendocrine tumor,

#651 Additional Value of New Molecular Imaging Tracers in the Detection of Recurrent/Residual Disease in Patients with Neuroendocrine Tumors

Introduction: Recent studies have proposed new molecular imaging tracers, such as 18F-DOPA and 68Ga-DOTANOC, for the detection of recurrent/residual neuroendocrine tumors (NET) in case of negative conventional imaging modalities.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Verga U, Filopanti M, Fugazzola L, Rodari M, Lopci E,

Keywords: 18F-DOPA, 68Ga-DOTANOC, recurrent/residual NET,

#263 Chronic Atrophic Gastritis Associated with Hyperparathyroidism: A prospective Study

Introduction: The association of gastric carcinoids (GCs) type 1 and hyperparathyroidism (HPTH) has been reported, whereas a possible association between chronic atrophic gastritis (CAG) and HPTH is still scant.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Massironi S, Rossi R, Spampatti M, Conte D, Verga U,

Keywords: chronic atrophic gastritis (CAG), hyperparathyroidism (HPTH), gastric carcinoids ,

#255 The Carcinoid Syndrome Caused by Retroperitoneal Carcinoid Tumors

Introduction: The carcinoid syndrome is caused by increased levels of serotonin and is mostly seen in cases of carcinoid tumor in the small bowel and liver metastases, as there is a very high first pass effect.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Wilson B, Nielsen H,

Keywords: carcinoid syndrome, NET, retroperitoneal mass,